AMANDA COOPER: Open Payments
NPI 1891387684 · ACWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 10 payments from 6 companies in 2025. Trend: 2023 $285 · 2024 $386 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $52 |
| Novo Nordisk Inc | 3 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| SANOFI-AVENTIS U.S. LLC | 1 | $14 |
Products named: SHINGRIX, Ozempic, GEMTESA, Rybelsus, TRELEGY ELLIPTA, UBRELVY, VOQUEZNA, TZIELD.
Industry payments across GA — which companies pay providers there.
